Post-effective Amendment to a Previously Filed F-6. (f-6 Pos)
2016年3月31日 - 5:51AM
Edgar (US Regulatory)
As filed with the Securities and Exchange Commission on
March 30, 2016
|
|
Registration No. 333-205847
|
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM F-6/A
POST-EFFECTIVE AMENDMENT NO. 1 TO
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933 FOR DEPOSITARY SHARES EVIDENCED BY
AMERICAN DEPOSITARY RECEIPTS
ONO PHARMACEUTICAL CO., LTD.
(Exact name of issuer of deposited securities as specified in its charter)
N/A
(Translation of issuer's name in English)
Japan
(Jurisdiction of incorporation or organization of issuer)
CITIBANK, N.A.
(Exact name of depositary as specified in its charter)
399 Park Avenue
New York, New York 10043
(212) 723-5435
(Address, including zip code, and telephone number, including area code, of depositary's principal executive offices)
CITIBANK, N.A. – DEPOSITARY RECEIPTS DEPARTMENT
388 Greenwich Street
New York, New York 10013
(877) 248-4237
(Name, address, including zip code, and telephone number, including area code of agent for service)
Copies to:
Herman H. Raspé, Esq.
Patterson Belknap Webb & Tyler LLP
1133 Avenue of the Americas
New York, New York 10036
|
It is proposed that this filing become effective under Rule 466:
|
|
o
|
|
|
|
|
x
|
April 4, 2016 at 8:30am (EST).
|
If a separate registration statement has been filed to register the deposited shares, check the following box:
o
CALCULATION OF REGISTRATION FEE
|
Title of Each Class of
Securities to be Registered
|
Amount to be
Registered
|
Proposed Maximum
Offering Price Per Unit*
|
Proposed Maximum Aggregate Offering Price**
|
Amount of
Registration Fee
|
American Depositary Shares (“
ADSs
”), each ADS representing the right to receive one-third (1/3) of one share of common stock of Ono Pharmaceutical Co., Ltd.
|
|
N/A
|
|
|
|
|
*
|
Each unit represents 100 ADSs.
|
|
|
**
|
Estimated solely for the purpose of calculating the registration fee. Pursuant to Rule 457(k), such estimate is computed on the basis of the maximum aggregate fees or charges to be imposed in connection with the issuance of ADSs.
|
PART I
INFORMATION REQUIRED IN PROSPECTUS
Cross Reference Sheet
Item 1. DESCRIPTION OF SECURITIES TO BE REGISTERED
|
Item Number and Caption
|
|
Location in Form of American
Depositary Receipt (“
Receipt
”)
Filed Herewith as Prospectus
|
|
|
|
|
|
|
1.
|
Name of Depositary and address of its principal executive office
|
|
Face of Receipt
- Introductory Article
|
|
|
|
|
|
|
|
2.
|
Title of Receipts and identity of deposited securities
|
|
Face of Receipt
- Top center
|
|
|
|
|
|
Terms of Deposit:
|
|
|
|
|
|
|
|
|
|
|
(i)
|
The amount of deposited securities represented by one American Depositary Share (“
ADS
”)
|
|
Face of Receipt
- Upper right corner
|
|
|
|
|
|
|
|
|
(ii)
|
The procedure for voting, if any, the deposited securities
|
|
Reverse of Receipt
- Paragraphs 12, 14 and 17
|
|
|
|
|
|
|
|
|
(iii)
|
The procedure for collecting and distributing dividends
|
|
Face of Receipt
- Paragraphs 4 and 8
Reverse of Receipt
- Paragraphs 13, 14 and 17
|
|
|
|
|
|
|
|
|
(iv)
|
The procedure for transmitting notices, reports and proxy soliciting material
|
|
Reverse of Receipt
- Paragraphs 11 and 12
|
|
|
|
|
|
|
|
|
(v)
|
The sale or exercise of rights
|
|
Reverse of Receipt
- Paragraphs 13 and 14
|
|
|
|
|
|
|
|
|
(vi)
|
The deposit or sale of securities resulting from dividends, splits or plans of reorganization
|
|
Face of Receipt
- Paragraphs 4 and 8
Reverse of Receipt
– Paragraphs 13, 14, 16 and 17
|
|
|
|
|
|
|
|
|
(vii)
|
Amendment, extension or termination of the deposit arrangements
|
|
Reverse of Receipt
– Paragraphs 18 and 19 (no provision for extension)
|
|
|
|
|
|
|
|
|
(viii)
|
The rights that holders of Receipts have to inspect the transfer books of the Depositary and the list of Receipt holders
|
|
Face of Receipt
- Paragraph 3
|
|
|
(ix)
|
Any restrictions on the right to transfer or withdraw the underlying securities
|
|
Face of Receipt
- Paragraphs 2, 4, 5, and 6
|
|
|
|
|
|
|
|
|
(x)
|
Any limitation on the Depositary’s liability
|
|
Face of Receipt
- Paragraphs 1 and 8;
Reverse of Receipt
- Paragraphs 12, 15 and 17
|
|
|
|
|
|
|
|
3.
|
Fees and charges that a holder of Receipts may have to pay, either directly or indirectly
|
|
Reverse of Receipt
– Paragraph 20
|
|
|
|
|
|
|
Item 2. AVAILABLE INFORMATION
|
|
Reverse of Receipt
- Paragraph 11
|
Based on the reasonable good faith belief of the Depositary after exercising reasonable diligence, the registrant represents that, as of the date hereof, Ono Pharmaceutical Co., Ltd. (the “
Company
”) publishes in English the information contemplated in Rule 12g3-2(b) under the United States Securities Exchange Act of 1934, as amended (the “
Exchange Act
”), on its internet website or through an electronic information delivery system generally available to the public in the Company's primary trading market. As of the date hereof the Company's internet website is www.ono.co.jp. The information so published by the Company cannot be retrieved from the Commission's internet website, and cannot be inspected or copied at the public reference facilities maintained by the Commission.
PROSPECTUS
IN ACCORDANCE WITH GENERAL INSTRUCTIONS III. B OF FORM F-6, THIS PAGE AND THE FORM OF AMERICAN DEPOSITARY RECEIPT ATTACHED AS AN EXHIBIT TO THIS POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT CONSTITUTE THE PROSPECTUS RELATING TO THE AMERICAN DEPOSITARY SHARES TO BE ISSUED PURSUANT TO THIS POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-6 REGISTRATION STATEMENT.
PART II
INFORMATION NOT REQUIRED IN PROSPECTUS
Item 3. EXHIBITS
(a) The agreement between Citibank, N.A., as depositary (the “
Depositary
”), and all holders and beneficial owners from time to time of American Depositary Shares registered hereunder. — Filed herewith.
(b) Any other agreement to which the Depositary is a party relating to the issuance of the American Depositary Shares registered hereunder or the custody of the deposited securities. — None.
(c) Every material contract relating to the deposited securities between the Depositary and the issuer of the deposited securities in effect at any time within the last three years. — None.
(d) Opinion of Patterson Belknap Webb & Tyler LLP, counsel for the Depositary, as to the legality of the securities to be registered. – Previously filed.
(e) Certification under Rule 466. — Filed herewith.
Item 4. UNDERTAKINGS
(a) The Depositary hereby undertakes to make available at the principal office of the Depositary in the United States, for inspection by holders of the Receipts, any reports and communications received from the issuer of the deposited securities which are both (1) received by the Depositary as the holder of the deposited securities, and (2) made generally available to the holders of the underlying securities by the issuer.
(b) The Depositary undertakes to prepare a separate document stating the amount of any fee charged and describing the service for which it is charged and to deliver promptly a copy of such fee schedule without charge to anyone upon request. The Depositary undertakes to notify each registered holder of a Receipt thirty days before any change in the fee schedule.
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that all the requirements for filing on Form F-6 are met and has duly caused this Post-Effective Amendment No. 1 Registration Statement on Form F-6 to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of New York, State of New York, on the 30th day of March, 2016.